Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease

NCT03419806 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER_GOV

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Infudopa i.v.
DRUG: Infudopa s.c.
DRUG: LCIG (Duodopa)

Sponsor

Vastra Gotaland Region

Collaborators

[object Object]
[object Object]
[object Object]